SCHEMBL3391480

SCHEMBL3391480

C=Cc1cc2c(C(=O)OCC)c(-c3ccc(Oc4ccc(F)cc4)cc3)oc2cc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.51
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
MAPT P10636 4/20 0.46
KDM4E B2RXH2 7/20 0.45
ALDH1A1 P00352 5/20 0.45
HPGD P15428 5/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
GAA P10253 2/20 0.43
TSHR P16473 2/20 0.43
HSD17B10 Q99714 2/20 0.43
HTT P42858 1/20 0.43
RCE1 Q9Y256 1/20 0.43
ALOX5 P09917 1/20 0.43
PRNP P04156 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12940365 0.96 ALOX5 (0.46) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL12940204 0.88 PTGS2 (0.55) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL2299840 0.88 MEN1 (0.56) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL4790812 0.86 PTGS2 (0.52) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL12940361 0.84 ALOX5 (0.51) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL2298170 0.84 PTGS2 (0.50) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL2297483 0.84 PTGS2 (0.50) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL6119870 0.83 ALOX5 (0.50) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL4792819 0.83 ALOX5 (0.45) PTGS2MEN1KMT2AMAPTKDM4E
SCHEMBL1918070 0.82 MEN1 (0.56) PTGS2MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245023-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2011-12-28 EP disclosed
EP-2245023-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2010-11-03 EP disclosed
WO-2009101022-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2009-08-20 WO disclosed